menu search

VYNE / 4 Penny Stocks That Are Trending on Reddit Right Now and Why

4 Penny Stocks That Are Trending on Reddit Right Now and Why
Are these Reddit penny stocks on your watchlist right now? The post 4 Penny Stocks That Are Trending on Reddit Right Now and Why appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com. Read More
Posted: Dec 9 2021, 13:42
Author Name: PennyStocks
Views: 111734

VYNE News  

VYNE Gains on Preclinical Data for IPF Candidate

By Zacks Investment Research
April 20, 2023

VYNE Gains on Preclinical Data for IPF Candidate

VYNE gains on positive preclinical data evaluating VYN201 for treating idiopathic pulmonary fibrosis. more_horizontal

VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates

By Zacks Investment Research
May 12, 2022

VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates

VYNE Therapeutics Inc. (VYNE) delivered earnings and revenue surprises of 6.67% and 67.64%, respectively, for the quarter ended March 2022. Do the num more_horizontal

VYNE Therapeutics to Present at LifeSci Partners' Immunology & Inflammation Symposium on May 10th

By GlobeNewsWire
May 6, 2022

VYNE Therapeutics to Present at LifeSci Partners' Immunology & Inflammation Symposium on May 10th

BRIDGEWATER, N.J., May 06, 2022 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a biopharmaceutical compa more_horizontal

3 Penny Stocks Under $1 That Are on Fire Today

By PennyStocks
April 7, 2022

3 Penny Stocks Under $1 That Are on Fire Today

Are these under $1 penny stocks worth buying this month? The post 3 Penny Stocks Under $1 That Are on Fire Today  appeared first on Penny Stocks to B more_horizontal

VYNE Therapeutics Shares Jump On Encouraging Preclinical Data From VYN201 Program In Rheumatoid Arthritis

By Benzinga
March 30, 2022

VYNE Therapeutics Shares Jump On Encouraging Preclinical Data From VYN201 Program In Rheumatoid Arthritis

VYNE Therapeutics Inc (NASDAQ: VYNE) announced positive preclinical data from its VYN201 program in the rheumatoid arthritis (RA) animal model. The more_horizontal

VYNE Therapeutics' BET Inhibitor Shows Encouraging Preclinical Action In Skin Disorder

By Benzinga
March 7, 2022

VYNE Therapeutics' BET Inhibitor Shows Encouraging Preclinical Action In Skin Disorder

VYNE Therapeutics Inc (NASDAQ: VYNE) has announced preclinical data in an ex vivo skin model of vitiligo, a chronic autoimmune depigmenting disor more_horizontal

VYNE Therapeutics' BET Inhibitor Shows Encouraging Preclinical Action In Skin Disorder

By Benzinga
March 7, 2022

VYNE Therapeutics' BET Inhibitor Shows Encouraging Preclinical Action In Skin Disorder

VYNE Therapeutics Inc (NASDAQ: VYNE) has announced preclinical data in an ex vivo skin model of vitiligo, a chronic autoimmune depigmenting disor more_horizontal

VYNE Therapeutics' BET Inhibitor Shows Encouraging Preclinical Action In Skin Disorder

By Benzinga
March 7, 2022

VYNE Therapeutics' BET Inhibitor Shows Encouraging Preclinical Action In Skin Disorder

VYNE Therapeutics Inc (NASDAQ: VYNE) has announced preclinical data in an ex vivo skin model of vitiligo, a chronic autoimmune depigmenting disor more_horizontal


Search within

Pages Search Results: